Second, several CD5, CD6, and/or CD166/ALCAM gene variants have been associated with different IMIDs, such as RA (38), lupus nephritis (39), MS (40–42), psoriasis (43), Behçet's disease (44), and IBD (45, 46) (Supplementary Table 2). Here, CD6 is linked to myeloid sarcoma.